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Abstract: Constraining a peptide in its bioactive confor-
mation by macrocyclization represents a powerful strategy
to design modulators of challenging biomolecular targets.
This holds particularly true for the development of inhibi-
tors of protein-protein interactions which often involve in-
terfaces lacking defined binding pockets. Such flat sur-
faces are demanding targets for traditional small mole-
cules rendering macrocyclic peptides promising scaffolds
for novel therapeutics. However, the contribution of pep-
tide dynamics to binding kinetics is barely understood
which impedes the design process. Herein, we report un-
expected trends in the binding kinetics of two closely re-
lated macrocyclic peptides that bind their receptor protein
with high affinity. Isothermal titration calorimetry, 19F NMR
experiments and molecular dynamics simulations reveal
that increased conformational flexibility of the macrocy-
cle–receptor complex reduces dissociation rates and con-
tributes to complex stability. This observation has impact
on macrocycle design strategies that have so far mainly
focused on the stabilization of bioactive ligand conforma-
tions.
Many therapeutically relevant bio-macromolecules cannot be
targeted with traditional small molecule approaches.[1] Often
these targets are characterized by relatively shallow surfaces as
they are frequently found at the interface of protein–protein
interactions (PPI).[2] Due to their excellent surface recognition
properties, large macrocyclic molecules are considered promis-
ing candidates to target protein areas involved in PPIs.[3] This
holds particularly true for peptide-derived macrocycles which
display favorable binding properties being linked to their large
surface areas as well as their unique structural and dynamic
characteristics.[4] Despite their constrained structure, they ex-
hibit considerable conformational freedom that allows for effi-
cient sampling of bioactive states.[3d,5] In many cases, the ef-
fects of macrocyclization on the thermodynamics of binding
are well investigated. Often, favorable entropic profiles result-
ing from reduced flexibilities of the free ligand translate into
increased affinities.[3d,6] However, the influence of macrocycliza-
tion on the conformational dynamics of the bound state and
the binding kinetics are less understood. Notably, the residence
time of a bound ligand (reciprocal of dissociation rate) is of
particular interest[7] as it strongly correlates with therapeutic ef-
ficacy.[8] Herein, we investigate two closely related peptide-de-
rived macrocyclic ligands (MC18 and MC22) binding the same
receptor protein (Figure 1a) but showing distinct binding char-
acteristics. Using isothermal titration calorimetry (ITC), 19F NMR
titration experiments and molecular dynamics (MD) simula-
tions, we show that increased conformational flexibility of the
macrocycle–receptor complex contributes to reduced dissocia-
tion rates and thereby to higher complex stability.
Previously, we reported a set of macrocycles derived from a
bacterial peptide binding epitope (L, grey) composed of 11
amino acids (Figure 1a).[6a] Two macrocyclic peptides show par-
ticularly high affinity for the receptor protein 14-3-3 isoform z
(from now on called 14-3-3) and were potent inhibitors of its
interaction with Exoenzyme S. One of these peptides compris-
es a macrocycle containing 18 atoms (MC18, blue) while the
other one bears a 22 atom ring system (MC22, red). MC22 dis-
plays the highest affinity for the receptor. The ligand–receptor
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complexes have been characterized via X-ray crystallography
verifying the central groove of 14-3-3 as the binding site for all
ligands (Figure 1b). In addition, it was shown that macrocycli-
zation indeed reduces flexibility in the free state of the ligand.
Having access to these well characterized ligand–receptor
pairs, we were interested in the impact of the different macro-
cyclization architectures on binding kinetics. For that purpose,
we decided to use 19F NMR spectroscopy which provides high
sensitivity for the detection of biomolecular interactions.[9] To
enable ligand-observed NMR experiments, the linear and both
macrocyclic peptides were synthesized and N-terminally modi-
fied with N-trifluoroacetyl glycine.
To elucidate binding thermodynamics of the fluorine-labeled
ligands, ITC experiments were performed (Figure 1c). Com-
pared to linear peptide L (dissociation constant, Kd=0.65 mm),
both macrocycles exhibit increased affinity for the receptor
(MC18 : Kd=0.36 mm, MC22 : Kd=0.11 mm). Binding of L is en-
thalpically driven (DH=@9.81 kcalmol@1) with negligible en-
tropic contribution (@TDS=@0.41 kcalmol@1). As expected,
both macrocyclic ligands show substantially increased entropic
contributions (@TDS=@3.75 and @4.34 kcalmol@1, for MC18
and MC22, respectively). Interestingly, this is accompanied by
reduced binding enthalpy (MC18 : 1.9-fold, MC22 : 1.8-fold), a
trend that is often referred to as enthalpy-entropy compensa-
tion.[10]
Having determined the thermodynamic parameters of all
ligand–receptor pairs, we applied 19F NMR spectroscopy to in-
vestigate the binding kinetics. 19F NMR spectra of all peptides
alone and in presence of varying receptor concentrations were
recorded. Free and bound ligand states are in slow exchange
on the 19F NMR chemical shift timescale (Figure 2a) with chem-
ical shift differences (Dd) of bound and free state resonances
Figure 1. a) Chemical structure of the core region of L, MC18 and MC22
(NR=N-trifluoroacetyl glycine-QG, CR=LDLAS) including affinity for 14–3-3
isoform z (derived from ITC) and cartoon representation of their bound con-
formation (PDB ID 4n7g, 4n7y, 4n84).[6a] b) Structure of receptor 14-3-3 in
cartoon representation (PDB ID 4n7y). c) Binding thermodynamics of ligand-
14-3-3 complexes (H=enthalpy, S=entropy, G=Gibbs energy, for details
see Supplementary methods and Figures S1–S3).
Figure 2. 19F NMR experiments and binding kinetics. a) 19F NMR spectra determined to investigate the interaction between ligands (L, MC18, MC22) and 14-3-
3. The concentration of 14-3-3 increases from top to bottom resulting in an increase of fraction bound (pb) for the ligands (for details see Supporting Informa-
tion methods and Figure S4 and S5). b) Binding kinetics for the interaction with 14-3-3. Dissociation rates (koff) were determined via
19F NMR line shape analy-
sis (Figure S6). Association rates (kon=koffVKd
@1) were calculated using koff-values and ITC-derived dissociation constants (Kd). Errors of Kd (ITC) account for the
standard deviation 1s (triplicate of measurements). Errors of koff (NMR) originate from the fitting procedure (Equation S1).
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ranging between 175 and 598 Hz. In this exchange regime,
19F NMR line shape analysis for the free ligands allows for the
determination of dissociation rates (koff, Figure 2b, Figures S4–
S6, Equations S1 and S2).[11] Notably, 14-3-3 proteins form
stable homodimers which only exchange very slowly under
our conditions.[12] This is supported by our NMR experiments
(Figure S7) and prevents interference with the determination
of ligand binding kinetics.[13]
Based on the koff values and ITC-derived dissociation con-
stants, association rates (kon=koffVKd
@1) were calculated. Com-
pared to L (kon=1.36V10
6 s@1M@1), both macrocyclic peptides
exhibit increased association rates (MC22 : kon=4.12V
106 s@1M@1, MC18 : kon=4.38V10
6 s@1M@1) clearly indicating a
beneficial effect of conformational constraint on the associa-
tion process. Strikingly, the dissociation rates of both macrocy-
cles differ considerably (Figure 2b). While MC18 (koff=1.58 s
@1)
exhibits accelerated dissociation compared to L (koff=0.89 s
@1),
MC22 (koff=0.45 s
@1) displays a lower dissociation rate. Since
both cyclic peptides show similar association rates, the superi-
or affinity of MC22 is a result of its lower dissociation rate.
Considering the closely related structures of MC18 and MC22
(Figure 1a), this is a remarkable observation.
The dissociation process is generally considered to be domi-
nated by the properties of the ligand–receptor complex.[8, 14]
The 19F NMR spectra provide information about the flexibility
of the bound ligand since decreases in linewidth (n0.5) correlate
with increased flexibility (Figure 2a).[15] Interestingly, this analy-
sis indicates higher flexibility for the bound state of macrocycle
MC22 (n0.5=12.4 Hz) compared to MC18 (n0.5=33.7 Hz) and
linear ligand L (n0.5=33.5 Hz). While this provides an initial in-
sight into the dynamic properties of these ligand–receptor
complexes, it is not clear if this is merely a local effect ob-
served for the fluorine label.
To dissect the different contributions to the properties of
the bound state, we employed MD simulations for all three
ligand–receptor complexes.[16] The corresponding crystal struc-
tures (PDB ID 4n7g, 4n7y, 4n84) served as a starting point for
these calculations. Ligands were prepared using Maestro[17]
and considered as they had been used in ITC and 19F NMR ex-
periments (including their N-terminal trifluoroacetyl glycine).
MD simulations were performed for 1.5 ms per complex taking
snapshots every 20 ps. Snapshots were clustered using a 2 a
cutoff for the minimum distance between clusters. The cluster
probability distributions served to calculate conformational en-
tropies (Sconf) which represent a measure for the conformation-
al flexibility of peptides and proteins.[18] Comparing conforma-
tional entropies of these ligand–receptor complexes with their
dissociation rates reveals a clear correlation (Figure 3a) indicat-
ing that increased flexibility of the complex is linked with re-
duced koff values. A closer look at the conformational entropies
reveals that the complex of MC22 (Sconf=7.5 kcalmol
@1) shows
increased flexibility compared to the complex of L and MC18
(Sconf=6.6 and 6.4 kcalmol
@1, Figure 3b) which is consistent
with the above mentioned narrower NMR linewidth (n0.5) for
the MC22–receptor complex. Interestingly, differences in the
overall flexibility appear to originate mainly from the ligands
(Figure 3b).
Considering the relatively high structural similarity of MC18
and MC22, we were interested to locate the regions responsi-
ble for the different flexibilities in the two receptor-bound
macrocycles. For that purpose, the root mean square fluctua-
tions (RMSF) were calculated for all main chain atoms and for
the carbon atoms within the ligand crosslink in MC18 (blue)
and MC22 (red, Figure 4a,b). Based on these RMSF values, the
two macrocycles display similar flexibilities within the peptide
core sequence (X1LDX2, Figure 4a, X=crosslinking amino
acids), but differ in their terminal regions and the crosslink
itself (Figure 4a,b). Here, MC22 shows considerably higher flex-
ibility than MC18 mainly contributing to overall differences in
conformational entropies of the bound state. A closer look at
both bound macrocycles including a color coding for RMSF
values illustrates these differences in flexibility (Figure 4c,d, in-
dicating low (white) to high (orange) flexibility). Both peptides
exhibit highest flexibility for their very terminal amino acids
which is in line with previously reported crystal structures
showing less defined electron density in these regions (PDB
ID: 4N7Y and 4N84).[6a] Notably, both termini in MC18 exhibit
lower flexibility than corresponding areas in MC22. In addition,
the crosslink in MC18 appears to be considerably more rigid
than in MC22. This behavior can be explained by the observa-
tion that the crosslink in MC18 reaches further into the hydro-
phobic groove of 14-3-3 (Figure S10 and S11) which may con-
strain its conformational freedom. Importantly, these MD find-
ings are in line with the decreased NMR linewidth for the N-
terminal fluorine label in MC22 (Figure 2a).
Taken together, these results provide mechanistic insight
into the contribution of peptide flexibility to receptor binding
using ITC and 19F NMR experiments combined with MD simula-
tions. Although both macrocycles exhibit similar thermody-
namic profiles, 19F NMR reveals intriguing differences in bind-
ing kinetics. Strikingly, reduced dissociation rates (and thereby
increased affinity) correlate with increased conformational flexi-
bilities of the ligand–receptor complex. This observation has
implications for the design of high affinity peptides and macro-
cycles which so far focused on the stabilization of a bioactive
conformation in the free state. Our findings suggest comple-
menting this strategy with a consideration of the bound state
Figure 3. MD-derived conformational entropies. a) Plot of conformational en-
tropies (Sconf) for ligand–receptor complexes versus dissociation rates (koff,
derived from 19F NMR). b) Total conformational entropies of ligand–receptor
complexes and individual contributions by ligand and receptor.
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aiming for increased flexibility. However, we cannot conclude
general design principles based on these initial findings. Taken
into consideration that in some cases crosslink incorporation
was also reported to result in a loss of entropic contributions
to binding,[19] any endeavor towards affinity maturation of
macrocyclic ligands is highly advised to involve a thorough
biophysical characterization of receptor binding. Even though,
such integrated optimization strategies are time and resource
demanding, they may provide the possibility to obtain ligands
with both increased affinity and prolonged residence time, of
which the latter is an important pharmacological parameter to-
wards high drug efficacy. In addition, our findings highlight the
potential of loop-like peptide epitopes as starting point for
macrocyclic ligands as they exhibit reduced intramolecular hy-
drogen bond stabilization when compared to repetitive sec-
ondary elements such as a-helix and b-sheet. Importantly,
loop-like epitopes are underrepresented in current stabilization
approaches that predominantly focus on a-helices.
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